Q3 2025 Terumo Corp Earnings Call Transcript
Key Points
- Terumo Corp (TRUMF) achieved all-time highs in revenue, operating income, and adjusted operating income for the third quarter.
- Revenue growth was 13% compared to the previous year, driven by strong demand in the US and favorable foreign exchange effects.
- Profit growth exceeded sales growth due to effective pricing policies and ongoing profitability improvement measures.
- The cardiovascular company, particularly TIS, made a significant contribution to sales growth.
- Strong sales performance was noted in the US and Europe, with double-digit growth in local currency terms.
- A one-time cost of CNY3 billion was recorded in the third quarter due to a portfolio review.
- Surging raw material prices and US tariff policies pose potential risks to the business environment.
- In emerging markets, the blood center business experienced a decline in sales compared to the previous year.
- The CDMO business in pharmaceuticals faced some delays, affecting progress.
- An impairment loss on equipment related to a new production line startup impacted profit increases.
Thank you for your kind introduction. I'm Hagimoto, Terumo's CFO. This presentation provides an overview of Terumo's financial results for the third quarter of the fiscal year ending March 31, 2025.
So here are the highlights of this financial statement. In the third quarter, we achieved all-time highs for revenue operating income, adjusted operating income and that income, both for the quarter and for the cumulative period up to the end of Q3. Revenue growth was 13% compared to the previous year. Driven by the US and continued global demand growth with foreign exchange effects also contributing profit growth exceeded sales growth due in part to the effects of pricing policy and ongoing efforts to improve profitability.
Next eye, please.
These are our PNO results. Revenues reached, as I have said at the outset, a record highs of CNY772.2 billion in the yulte period up to the end of Q3.
In addition to continued demand growth in a generally favorable business environment, foreign exchange effects also contributed.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
